A study of patients with chemotherapy-related peripheral neuropathy showed 59% of those who took the antidepressant drug Cymbalta reported some pain relief, while 38% of those in the placebo group saw improvement. The results were published in the Journal of the American Medical Association.
Cymbalta eases chemo-linked pain, study finds
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||